| id | C00000297 |
|---|---|
| Name | Psoralen |
| CAS RN | 66-97-7 |
| Standard InChI | InChI=1S/C11H6O3/c12-11-2-1-7-5-8-3-4-13-9(8)6-10(7)14-11/h1-6H |
| Standard InChI (Main Layer) | InChI=1S/C11H6O3/c12-11-2-1-7-5-8-3-4-13-9(8)6-10(7)14-11/h1-6H |
| Phytochemical cluster | No. 25 |
|---|---|
| KCF-S cluster | No. 1282 |
| By standard InChI | CHEMBL164660 |
|---|---|
| By standard InChI Main Layer | CHEMBL164660 |
| By LinkDB | C09305 |
|---|
| By CAS RN | D005363 |
|---|
| accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|---|
| P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | CHEMBL164660 |
CHEMBL1614110
(1)
|
1 / 0 |
| P20813 | Cytochrome P450 2B6 | Cytochrome P450 2B6 | CHEMBL164660 |
CHEMBL1743495
(2)
|
1 / 0 |
| P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | CHEMBL164660 |
CHEMBL1614027
(1)
|
0 / 1 |
| P11388 | DNA topoisomerase 2-alpha | Isomerase | CHEMBL164660 |
CHEMBL1034330
(1)
|
0 / 0 |
| P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | CHEMBL164660 |
CHEMBL1743539
(2)
|
0 / 0 |
| P83916 | Chromobox protein homolog 1 | Unclassified protein | CHEMBL164660 |
CHEMBL1794401
(1)
|
0 / 0 |
| P56817 | Beta-secretase 1 | A1A | CHEMBL164660 |
CHEMBL1936881
(1)
CHEMBL1936882
(1)
|
0 / 0 |
| Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | CHEMBL164660 |
CHEMBL1613910
(1)
CHEMBL1614227
(1)
|
3 / 3 |
| P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | CHEMBL164660 |
CHEMBL1291967
(1)
|
0 / 0 |
| P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | CHEMBL164660 |
CHEMBL1613777
(1)
|
1 / 1 |
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | CHEMBL164660 |
CHEMBL1614108
(1)
CHEMBL1613886
(1)
|
0 / 1 |
| B2RXH2 | Lysine-specific demethylase 4E | Enzyme | CHEMBL164660 |
CHEMBL1613914
(1)
|
0 / 0 |
| OMIM | preferred title | UniProt |
|---|---|---|
| #300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
| #609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
| #608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
| #614546 | Efavirenz, poor metabolism of |
P20813
|
| #300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
| #300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
| KEGG | disease name | UniProt |
|---|---|---|
| H00036 | Osteosarcoma |
P08684
(marker)
|
| H01205 | Coumarin resistance |
P11712
(related)
|
| H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
| H00480 | Non-syndromic X-linked mental retardation |
Q99714
(related)
|
| H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
| H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
| MeSH disease | OMIM | compound | disease name | evidence type |
reference
pmid |
|---|---|---|---|---|---|
| D000647 | D005363 | Amnesia |
therapeutic
|
17318785
|
|
| D002280 | D005363 | Carcinoma, Basal Cell |
marker/mechanism
|
11511317
|
|
| D017484 | D005363 | Dermatitis, Phototoxic |
marker/mechanism
|
9361129
|
|
| D056486 | D005363 | Drug-Induced Liver Injury |
marker/mechanism
|
22173200
|
|
| D011565 | D005363 | Psoriasis |
therapeutic
|
14746632
|